The Medical Letter
$19.99
The The Medical Letter subscription delivers independent, unbiased appraisals of drugs and treatments — critical reviews of new medicines and head-to-head comparisons of options, funded by no pharmaceutical company and driven by evidence alone.
Independent drug appraisals, free of industry influence
The The Medical Letter subscription exists to answer one question honestly: is this new drug actually better? Its critical reviews appraise new medicines and compare therapeutic options head to head, and because it accepts no pharmaceutical-industry funding, its recommendations rest on evidence rather than marketing — a rare thing in drug information.
Inside this resource
Critical, not promotional
Each review takes a new drug and asks what the evidence really shows about its benefit, harm and place in therapy — a critical appraisal rather than the optimistic framing that surrounds a product launch.
Comparisons in The Medical Letter subscription
Head-to-head comparisons of treatment options are the heart of its usefulness: not just whether a drug works, but whether it works better than what you already prescribe, which is the decision that actually faces a clinician.
Independent by design
It takes no funding from the pharmaceutical industry, and that independence is the whole point — the recommendations are shaped by evidence alone, giving you a source you can weigh against the promotional material that fills your inbox.
Who this serves
- Prescribing clinicians — an honest read on whether a new drug is worth switching to.
- Formulary and P&T committees — independent comparisons to inform coverage decisions.
- Pharmacists — evidence-first appraisals free of industry framing.
Before you buy
Is it independent of drug companies?
Yes — it accepts no pharmaceutical-industry funding, so its recommendations are based purely on evidence.
Does it compare treatments?
Yes — head-to-head comparisons of therapeutic options are central to what it offers.
The chart
| Format | Clinical reference (subscription) |
|---|---|
| Approach | Independent, industry-free reviews |
| Content | New-drug appraisals and comparisons |
| Publisher | The Medical Letter |
| Department | Research |
| Delivery | Emailed once your order is verified |
5 reviews for The Medical Letter
Add a review
Related products
Journals
Journals
Research
Research
Journals
Research
Research
D. Rossi –
Refreshingly critical. It will tell you a shiny new drug adds little, which is worth a lot.
pt_committee –
We lean on the head-to-head comparisons for formulary decisions. Independent and evidence-first — exactly what a P&T committee needs.
Dr. Grace H. –
The one drug source I trust precisely because it takes no industry money. Its verdict on a new agent talked me out of an expensive switch that the reps were pushing hard.
Dr. Aiko M. –
Concise and honest appraisals. I read it before believing any launch hype now.
pharm_neil –
Invaluable for unbiased reviews. It is text-focused rather than flashy, and coverage follows what is newly relevant, but the independence is unmatched.